VISCHER advised Danstar Ferment AG on the Swiss legal aspects of this transaction. Danstar Ferment AG, a Swiss subsidiary of Canadian multi-national, Lallemand Inc., has successfully...
You must be a Standard 1 Year member to access this content.
VISCHER advised Oberland Capital in this transaction. Oberland Capital Management LLC signed a financing agreement with the Helsinn Group. Oberland Capital is a private investment firm...
You must be a Standard 1 Year member to access this content.
Vischer advised Norgine Ventures on the deal. Norgine Ventures has provided financing of approx. EUR 10 million to Lunaphore Technologies.The financing was realised in form of...
You must be a Standard 1 Year member to access this content.
Vischer, Advestra and Grandway advised Ningbo Shanshan on the deal. Niederer Kraft Frey has advised the underwriters led by Huatai Financial Holdings (Hong Kong) Limited and...
You must be a Standard 1 Year member to access this content.
White & Case and Vischer advised Advanz Pharma on the deal. Advanz Pharma announced its acquisition of the ex-US business of Intercept Pharmaceuticals. ADVANZ PHARMA is a...
You must be a Standard 1 Year member to access this content.
Niederer Kraft Frey has advised Credit Suisse on the deal. Lenz & Staehelin advised Gilde Buy Out Partners in this transaction. VISCHER advised the co-founders and...
You must be a Standard 1 Year member to access this content.
VISCHER advised the buyer on this transaction. Bär & Karrer acts as legal advisor to exceet Group in this transaction. A fund advised by AFINUM Management...
You must be a Standard 1 Year member to access this content.
SKYE PARTNERS, Weil, Gotshal & Manges, Clifford Chance, Pusch Wahlig Workplace Law, BCA-Law, DMZ Legal, herrmann legal, Disput Hübner and Vischer advised Invision. Baker McKenzie advised...
You must be a Standard 1 Year member to access this content.
VISCHER advised the sellers on this transaction. Wenger Vieli advised Atlas Antibodies. The shareholders of the evitria Group have sold the evitria Group to Atlas Antibodies,...
You must be a Standard 1 Year member to access this content.
VISCHER acted as Swiss counsel to Dermavant in the transaction. Dermavant Sciences, a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative therapeutics in immuno-dermatology, entered...
You must be a Standard 1 Year member to access this content.
